Latest News Archive

Please select Category, Year, and then Month to display items

UFS Modular Lecture Building gets national recognition

11 May 2023 | Story Samkelo Fetile | Photo iFlair Photography

The University of the Free State’s (UFS) Modular Lecture Building on its Bloemfontein Campus recently received a National Merit Award from the South African Institute of Architects (SAIA). The awards were announced at the 2021/2022 Corobrik SAIA Awards of Merit and Awards for Excellence ceremony in Johannesburg.

The multi-functional Modular Lecture Building, considered a hub for innovative learning, was designed by Roodt Architects in partnership with GXY Architects.

The adjudication panel received a total of 42 architectural projects from around the country, including infrastructure developments in the public and private sector. The SAIA Awards programme is structured over a two-year period and is conducted in two stages. In stage one regional awards for architecture are presented by the nine regional institutes affiliated to SAIA. In stage two the winning regional projects that are consequently entered into the national awards receive either a Commendation, an Award of Merit, and/or an Award for Excellence, which recognises exceptional achievement in the field of architecture.

In their citation the adjudicators noted that the Modular Lecture Building sets a benchmark for rational planning and technical efficiency and helps complete the campus urban framework through its placing and material choices.

Multi-functional spaces for students

Nico Janse van Rensburg, Senior Director at UFS University Estates, said the recognition is a testament to the UFS’s aspirations to renew, rejuvenate, regenerate, and revisit facilities and infrastructure.

“This award proves that excellence can be achieved with a reasonable set budget,” Janse van Rensburg said. “Energy efficiency and green building principles can be achieved by careful planning and teamwork.”

The Modular Lecture Building offers a variety of much-needed flexible teaching and learning spaces. “I have been using the facilities in this building for two years now, and I can say the building is much more spacious and conducive to studying,” said Hymne Spies, a third-year BSc student majoring in biochemistry and genetics. “The many plugs make it more efficient for studying, as one can plug in his or her laptop. There is also a nice computer lab for us to make use of.”

The UFS is proud that the construction of this facility forms part of a bigger endeavour – to create a cohesive campus identity that improves core business and to further extend its innovation and excellence as per its Vision 130.

Take a tour of the new Modular Lecturing Space and Assessment Centre Building:

News Archive

New research informs improved treatment of brain inflammation

2017-10-13

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish

Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept